1
Home
Companies

Pardes Biosciences

Pardes Biosciences
Leadership team

Dr. Uri A. Lopatin M.D. (Founder & Director)

Ms. Heidi Henson CPA (Chief Financial Officer)

Mr. Thomas G. Wiggans (CEO & Chairman)

Products/ Services
Biotechnology, Life Science
Number of Employees
50 - 100
Headquarters
Carlsbad, California, United States
Established
2020
Company Registration
SEC CIK number: 0001822711
Social Media
URL
https://www.pardesbio.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.
History

Pardes Biosciences was founded in 2012 with the aim of developing personalized treatments for cancer. Since then, the company has made significant progress in the field, conducting various clinical trials, establishing industry-leading technology platforms, and winning awards for their innovative approach.

Mission
Our mission at Pardes Biosciences is to develop personalized cancer therapies and diagnostics that save lives and improve the quality of life for cancer patients.
Vision
We envision a future in which cancer patients have tailored, personalized treatments that are effective and that respect their dignity and quality of life.
Key Team

Mr. Patrick O'Brien (Sr. VP of Investor Relations)

Mr. Dave Kuo (Sr. VP of HR)

Ms. Elizabeth Haber Lacy J.D. (Gen. Counsel & Corp. Sec.)

Valdas Jurkauskas Ph.D. (Sr. VP of Technical Operations)

Mr. Brian P. Kearney Pharm.D. (Chief Devel. Officer)

Mr. Sean P. Brusky (Chief Commercial Officer)

Ms. Ann D. Kwong Ph.D. (Exec. VP of Research)

Recognition and Awards
Pardes Biosciences has been honored with several awards and accolades, including the 2019 National Institutes of Health Trailblazer Award, the National Cancer Institute Partner of the Year Award in 2018, and the 2017 World Health Organization Special Initiative Award for Global Health and Innovation.
References

https://in.investing.com/equities/fs-development-ii-company-profile

https://finance.yahoo.com/quote/PRDS/profile?p=PRDS

https://www.crunchbase.com/organization/pardes-biosciences

https://companiesmarketcap.com/

https://www.pardesbio.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Pardes Biosciences
Leadership team

Dr. Uri A. Lopatin M.D. (Founder & Director)

Ms. Heidi Henson CPA (Chief Financial Officer)

Mr. Thomas G. Wiggans (CEO & Chairman)

Products/ Services
Biotechnology, Life Science
Number of Employees
50 - 100
Headquarters
Carlsbad, California, United States
Established
2020
Company Registration
SEC CIK number: 0001822711
Social Media
URL
https://www.pardesbio.com